Company Profiles

driven by the PitchBook Platform

Cognition Therapeutics

Description

Developer of small molecule therapeutics for neurodegenerative diseases. The company uses proprietary biology and chemistry platforms to discover novel drug targets and disease modifying therapies for disorders of the central nervous system.

2007

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$6.47M

Latest Deal Amount

$33.2M

Total Amount Raised

Description

Developer of small molecule therapeutics for neurodegenerative diseases. The company uses proprietary biology and chemistry platforms to discover novel drug targets and disease modifying therapies for disorders of the central nervous system.

Website:

www.cogrx.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

2403 Sidney Street Suite 261 Pittsburgh, PA 15203United States +1 (412) 481-2210
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Cognition Therapeutics's full profile, request a free trial.

Cognition Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Cognition Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Cognition Therapeutics Investors (25)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
2M CompaniesFamily OfficeMinority000 0000000 0000
ACE FundOtherMinority000 0000000 0000
Alzheimers Drug Discovery FoundationOtherMinority000 0000000 0000
Anteon InternationalCorporationMinority000 0000000 0000
Ariel Southeast Angel PartnersAngel GroupMinority000 0000000 0000
2M Companies Family Office
ACE Fund Other
Alzheimers Drug Discovery Foundation Other
Anteon International Corporation
Ariel Southeast Angel Partners Angel Group

Cognition Therapeutics Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Kenneth MochPresident, Chief Executive Officer and Board Member
Susan Catalano Ph.DCo-Founder, Chief Scientific Officer & Board Member
Harold Safferstein Ph.DSenior Vice President of Corporate Development
Stephen DiPalmaChief Financial Officer
Gilbert Rishton Ph.DCo-Founder & Chief Medicinal Chemistry Advisor
Kenneth Moch President, Chief Executive Officer and Board Member
Susan Catalano Ph.D Co-Founder, Chief Scientific Officer & Board Member
Harold Safferstein Ph.D Senior Vice President of Corporate Development
Stephen DiPalma Chief Financial Officer
Gilbert Rishton Ph.D Co-Founder & Chief Medicinal Chemistry Advisor

Cognition Therapeutics Board Members (7)

NameRepresentingRoleSinceContact
Info
Aaron Fletcher Ph.DBios Memory SPV 1, LPExecutive000 0000
Irwin Scher MDSelfBoard Member000 0000
Kenneth MochCognition TherapeuticsPresident, Chief Executive Officer and Board Member000 0000
Mark BreedloveSelfBoard Member000 0000
Peggy WallaceGolden SeedsManaging Partner000 0000
Aaron Fletcher Ph.D Executive Bios Memory SPV 1, LP
Irwin Scher MD Board Member Self
Kenneth Moch President, Chief Executive Officer and Board Member Cognition Therapeutics
Mark Breedlove Board Member Self
Peggy Wallace Managing Partner Golden Seeds
Request full access to PitchBook